Compared with the existing MYCN-driven mouse model of neuroblastoma, which expresses a human MYCN cDNA under the control of a rat tyrosine hydroxylase promoter,6 the novel LSL-MYCN;Dbh-iCre bears several advantages. The gene discussed is MYCN; the disease is neuroblastoma.